Skip to content
Screener

Bio-Techne TECH Protein Sciences — Operating Income

Other segment segments

Diagnostics And Spatial Biology
$10.32M+22.5%

Similar metrics at other companies

Ashland logo
ASHLife Sciences — Operating Income
$45M+113%
Ecolab logo
ECLGlobal Life Sciences — Operating Income
$58.5M+45.5%
RCM Technologies logo
RCMTLife Sciences Data Solutions — Operating Income
$2.05M-3.7%
WAT
WATWaters Analytical And Materials Sciences — Operating Income
$236M+9.8%
Lincoln Educational Services Corporation logo
LINCCampus Operations — Operating Income
$27.73M+28.0%
DWS
DWSNCanada Operations — Operating Income
$5.4M-2.8%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemProtein SciencesDiagnostics and Spatial BiologyTotal
Cost of sales53,79438,649
Selling, general and administrative57,90927,616
Research and development14,4529,002
Segment operating income$$99,999$10,319110,318
Unallocated amounts
Amortization of intangibles(15,382)
Acquisition related expenses and other(897)
Certain litigation charges(822)

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's protein sciences — operating income?
Bio-Techne (TECH) reported protein sciences — operating income of $100M in Q1 2026.
How has Bio-Techne's protein sciences — operating income changed year-over-year?
Bio-Techne's protein sciences — operating income decreased by 3.8% year-over-year, from $103.91M to $100M.
What is the long-term trend for Bio-Techne's protein sciences — operating income?
Over 3 years (2022 to 2025), Bio-Techne's protein sciences — operating income has grown at a -0.6% compound annual growth rate (CAGR), from $377.62M to $370.35M.
What does protein sciences — operating income mean?
This is the profit or loss generated by the Protein Sciences segment after deducting cost of goods sold, SG&A, and R&D expenses from total segment revenue. It measures the core operational profitability of the segment before interest, taxes, and corporate-level allocations. It is the primary metric for evaluating the segment's contribution to the overall company's bottom line.

Ask your AI about Bio-Techne's protein sciences — operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude